Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-024074
Filing Date
2019-09-23
Accepted
2019-09-23 20:01:52
Documents
1
Period of Report
2019-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5159
  Complete submission text file 0000899243-19-024074.txt   6688
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Issuer) CIK: 0001463361 (see all company filings)

EIN.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 343 OYSTER POINT BLVD SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address
Goeltz II Robert C. (Reporting) CIK: 0001653881 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38470 | Film No.: 191109028